Canadian healthcare professionals who applied for Section 56 exemptions to the Controlled Drugs and Substances Act (CDSA) this past summer have been waiting exactly 150 days for a response from Minister Patty Hajdu.
In July, Victoria-based nonprofit organization Therapsil announced that in addition to assisting four terminally ill patients in applying for exemptions to use psilocybin for end-of-life therapy, it would assist doctors who wanted to apply to have their own experiences with psilocybin so they could better understand its therapeutic potential.
Share this post
